{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:03:36Z","timestamp":1784257416219,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012539","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000}}],"reference-count":79,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012539.pub2","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T09:37:33Z","timestamp":1501753053000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents"],"prefix":"10.1002","volume":"2019","author":[{"given":"Tess E","family":"Cooper","sequence":"first","affiliation":[{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Fisher","sequence":"additional","affiliation":[{"name":"Pain Research Unit, Churchill Hospital; Cochrane Pain, Palliative and Supportive Care Group; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Anderson","sequence":"additional","affiliation":[{"name":"Starship Children\u2019s Hospital; Paediatric Intensive Care Unit; Park Road, Grafton Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick MR","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Evelina London Children's Hospital, Guys & St Thomas's NHS Foundation Trust; Westminster Bridge Road London UK SE1 7EH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G","family":"Williams","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital for Children NHS Foundation Trust; Anaesthesia; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Eccleston","sequence":"additional","affiliation":[{"name":"Pain Research Unit, Churchill Hospital; Cochrane Pain, Palliative and Supportive Care Group; Oxford UK"},{"name":"University of Bath; Centre for Pain Research; Claverton Down Bath UK"},{"name":"Ghent University; Department of Clinical and Health Psychology; Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD012539.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1185\/030079907X182239","article-title":"Efficacy of a paracetamol and caffeine combination in the treatment of the key symptoms of primary dysmenorrhoea","volume":"23","author":"Ali","year":"2007","journal-title":"Current Medical Research and Opinion"},{"issue":"4","key":"10.1002\/14651858.CD012539.pub2-BIB0002|cit2","first-page":"361","article-title":"Relief of severe pain with acetaminophen in a new dose formulation versus propoxyphene hydrochloride 65 mg. and placebo: a comparative double-blind study","volume":"17","author":"Berry","year":"1975","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00520-009-0649-8","article-title":"Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of concologic patients: a prospective, randomized, double-blind, placebo-controlled study","volume":"18","author":"Cubero","year":"2010","journal-title":"Support Care Cancer"},{"issue":"11","key":"10.1002\/14651858.CD012539.pub2-BIB0004|cit4","first-page":"452","article-title":"A double-blind comparative trial of 'parazolidin' and paracetamol","volume":"23","author":"McGuinness","year":"1969","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/j.1365-2036.2006.02818.x","article-title":"Placebo- and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain","volume":"23","author":"Mueller-Lissner","year":"2005","journal-title":"Alimentary Pharmacology & Therapies"},{"issue":"9","key":"10.1002\/14651858.CD012539.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1185\/03007999209111527","article-title":"Controlled trial of a back support ('Lumbotrain') in patients with non-specific low back pain","volume":"12","author":"Valle-Jones","year":"1992","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0007|cit7","unstructured":"American Medical Association Pediatric pain management https:\/\/www.ama-assn.org\/"},{"issue":"9","key":"10.1002\/14651858.CD012539.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1517\/17425255.2015.1061505","article-title":"Considerations when using PKPD modelling to determine effectiveness of simple analgesics in children","volume":"11","author":"Anderson","year":"2015","journal-title":"Expert Opinion on Drug Metabolism and Toxicology"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0009|cit9","unstructured":"Cochrane Pain Palliative and Supportive Care Group PaPaS author and referee guidance papas.cochrane.org\/papas-documents"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0010|cit10","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2016"},{"issue":"2","key":"10.1002\/14651858.CD012539.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/j.pain.0000000000000403","article-title":"A comprehensive categorical and bibliometric analysis of published research articles on pediatric pain from 1975 to 2010","volume":"157","author":"Caes","year":"2016","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/CIRCULATIONAHA.105.595793","article-title":"Nonsteroidal anti inflammatory drugs, acetaminophen, and the risk of cardiovascular events","volume":"113","author":"Chan","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.1002\/14651858.CD012539.pub2-BIB0013|cit13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012538.pub2","article-title":"Opioids for chronic non-cancer pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012539.pub2-BIB0014|cit14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012535.pub2","article-title":"Antidepressants for chronic non-cancer pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012539.pub2-BIB0015|cit15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012563.pub2","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5694\/j.1326-5377.2008.tb01625.x","article-title":"Guidelines for the management of paracetamol poisoning in Australia and New Zealand - explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres","volume":"188","author":"Daly","year":"2008","journal-title":"Medical Journal of Australia"},{"issue":"4","key":"10.1002\/14651858.CD012539.pub2-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008040.pub3","article-title":"Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults","author":"Derry","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012539.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1136\/bmj.326.7404.1408","article-title":"Management of chronic pain in children and adolescents (Editorial)","volume":"326","author":"Eccleston","year":"2003","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD012539.pub2-BIB0020|cit20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012537.pub2","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents","author":"Eccleston","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0021|cit21","unstructured":"US Food Drug Administration Acetaminophen information www.fda.gov\/Drugs\/DrugSafety\/InformationbyDrugClass\/ucm165107.htm"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/01.HYP.0000177437.07240.70","article-title":"Non-narcotic analgesic dose and risk of incident hypertension in US women","volume":"46","author":"Forman","year":"2005","journal-title":"Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD012539.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003088-198207020-00001","article-title":"Clinical pharmacokinetics of paracetamol","volume":"7","author":"Forrest","year":"1982","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","article-title":"The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings","volume":"21","author":"Graham","year":"2013","journal-title":"Inflammopharmacology"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012539.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"Making an overall rating of the confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012539.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables - binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0029|cit29","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1096\/fj.07-8506com","article-title":"Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man","volume":"22","author":"Hinz","year":"2008","journal-title":"FASEB Journal"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2011.200087","article-title":"Paracetamol and cyclooxygenase inhibition: is there a cause for concern?","volume":"71","author":"Hinz","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD012539.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0033|cit33","first-page":"11","article-title":"Paracetamol: mechanism of action, applications and safety concern","volume":"71","author":"Jozwiak-Bebenista","year":"2014","journal-title":"Acta Poloniae Pharmaceutica"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"h1225","DOI":"10.1136\/bmj.h1225","article-title":"Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials","volume":"350","author":"Machado","year":"2015","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD012539.pub2-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001751.pub3","article-title":"Nonsteroidal anti-inflammatory drugs for dysmenorrhoea","author":"Marjoribanks","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0037|cit37","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"issue":"7","key":"10.1002\/14651858.CD012539.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0039|cit39","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD012539.pub2-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012539.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012539.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012539.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012539.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.2013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pain.2009.08.007","article-title":"Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD012539.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD012539.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"2","key":"10.1002\/14651858.CD012539.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD012539.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012539.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"1","key":"10.1002\/14651858.CD012539.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"issue":"9","key":"10.1002\/14651858.CD012539.pub2-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008659.pub3","article-title":"Single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/ejhpharm-2016-000952","article-title":"Paracetamol and pain: the kiloton problem","volume":"23","author":"Moore","year":"2016","journal-title":"European Journal of Hospital Pharmacy"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0055|cit55","unstructured":"National Institute for Health and Care Excellence Analgesia - mild-to-moderate pain cks.nice.org.uk\/analgesia-mild-to-moderate-pain#!scenario:1"},{"issue":"1","key":"10.1002\/14651858.CD012539.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"issue":"10","key":"10.1002\/14651858.CD012539.pub2-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011219.pub3","article-title":"Paracetamol (acetaminophen) for prevention or treatment of pain in newborns","author":"Ohlsson","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD012539.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jpain.2008.04.007","article-title":"Core outcome domains and measures for pediatric acute and chronic\/recurrent pain clinical trials: PedIMMPACT","volume":"9","author":"McGrath","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0059|cit59","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.critrevonc.2008.12.005","article-title":"Pain therapy","volume":"70","author":"Ripamonti","year":"2008","journal-title":"Journal of Oncology and Hematology"},{"issue":"3","key":"10.1002\/14651858.CD012539.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/annrheumdis-2014-206914","article-title":"Paracetamol: not as safe as we thought? A systematic literature review of observational studies","volume":"75","author":"Roberts","year":"2016","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD012539.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012230","article-title":"Paracetamol for low back pain","author":"Saragiotto","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/qjmed\/95.9.609","article-title":"Paracetamol toxicity: epidemiology, prevention and costs to the health-care system","volume":"95","author":"Sheen","year":"2002","journal-title":"QJM: An International Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012539.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1248\/bpb.30.157","article-title":"Pharamcokinetics\/pharmacodynamics of acetaminophen analgesia in Japanese patients with chronic pain","volume":"30","author":"Shinoda","year":"2007","journal-title":"Biological and Pharmaceutical Bulletin"},{"issue":"12","key":"10.1002\/14651858.CD012539.pub2-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011534.pub2","article-title":"Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children","author":"Sjoukes","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1-2","key":"10.1002\/14651858.CD012539.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pain.2006.05.006","article-title":"Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents","volume":"125","author":"Stinson","year":"2006","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012539.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0070|cit70","unstructured":"Therapeutic Goods Administration Reccomended paracetamol doses www.tga.gov.au\/community-qa\/recommended-paracetamol-doses"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0071|cit71","unstructured":"United Nations World population prospects 2015 - population indicators esa.un.org\/unpd\/wpp\/Download\/Standard\/Population\/"},{"issue":"1-2","key":"10.1002\/14651858.CD012539.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pain.2006.08.014","article-title":"Systematic review of observational (behavioural) measures of pain for children and adolescents aged 3 to 18 years","volume":"127","author":"Baeyer","year":"2007","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0073|cit73","unstructured":"World Health Organization WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses WHO Press, World Health Organization 2012"},{"issue":"12","key":"10.1002\/14651858.CD012539.pub2-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012227.pub2","article-title":"Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults","author":"Wiffen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012539.pub2-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012564.pub2","article-title":"Opioids for cancer-related pain in children and adolescents","author":"Wiffen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012539.pub2-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012536.pub2","article-title":"Antiepileptic drugs for chronic non-cancer pain in children and adolescents","author":"Wiffen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD012539.pub2-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009572.pub2","article-title":"Combined and alternating paracetamol and ibuprofen therapy for febrile children","author":"Wong","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012539.pub2-BIB0078|cit78","unstructured":"World Bank Data - population ages 0-14 (% of total) data.worldbank.org\/indicator\/SP.POP.0014.TO.ZS"},{"issue":"1","key":"10.1002\/14651858.CD012539.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/0960327114531993","article-title":"Worldwide research productivity of paracetamol (acetaminophen) poisoning: a bibliometric analysis (2003-2012)","volume":"34","author":"Zyoud","year":"2015","journal-title":"Human and Experimental Toxicology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012539.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T07:17:00Z","timestamp":1688195820000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012539.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":79,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012539.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,2]]}}}